UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Towards Effective Implementation of Carbon Reduction Strategies in Construction Procurement: A Case Study of New Zealand

Buildings (Basel), 2022-10, Vol.12 (10), p.1570

2022

Volltextzugriff (PDF)

Augmenting external control arms using Bayesian borrowing: a case study in first-line non-small cell lung cancer

Journal of comparative effectiveness research, 2024-05, Vol.13 (5), p.e230175-e230175

2024

Volltextzugriff (PDF)

Microbial Transformations of Selenium Species of Relevance to Bioremediation

Applied and environmental microbiology, 2016-08, Vol.82 (16), p.4848-4859

2016

Volltextzugriff (PDF)

266 Tumour mutation burden (TMB) and efficacy outcomes in the phase III DANUBE study of advanced urothelial carcinoma (UC)

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A163-A164

2020

Volltextzugriff (PDF)

Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study

Journal of clinical oncology, 2021-09, Vol.39 (27), p.2991-3001

2021

Volltextzugriff (PDF)

Methyl Selenol as a Precursor in Selenite Reduction to Se/S Species by Methane-Oxidizing Bacteria

Applied and environmental microbiology, 2019-11, Vol.85 (22)

2019

Volltextzugriff (PDF)

Factors Influencing the Surface Functionalization of Citrate Stabilized Gold Nanoparticles with Cysteamine, 3-Mercaptopropionic Acid or l-Selenocystine for Sensor Applications

Chemosensors, 2020-09, Vol.8 (3), p.80

2020

Volltextzugriff (PDF)

Development of a method for the simultaneous detection of Cr(iii) and Cr(vi) in exhaled breath condensate samples using μLC-ICP-MS

Journal of analytical atomic spectrometry, 2016-01, Vol.31 (4), p.924-933

2016

Volltextzugriff (PDF)

Exposure-Response Analyses of Tremelimumab Monotherapy or in Combination with Durvalumab in Patients with Unresectable Hepatocellular Carcinoma

Clinical cancer research, 2023-02, Vol.29 (4), p.754-763

2023

Volltextzugriff (PDF)

A phase 3 randomized, double-blind, placebo-controlled, multicenter, global study of durvalumab with and after chemoradiotherapy in patients with locally advanced, unresectable esophageal squamous cell carcinoma: KUNLUN

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.TPS373-TPS373

2022

Volltextzugriff (PDF)

Tumor Mutational Burden as a Predictor of Survival with Durvalumab and/or Tremelimumab Treatment in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Clinical cancer research, 2023-06, Vol.29 (11), p.2066-2074

2023

Volltextzugriff (PDF)

Research productivity and impact of Canadian academic ophthalmologists: trends in H-index, gender, subspecialty, and faculty appointment

Canadian journal of ophthalmology, 2022-06, Vol.57 (3), p.188-194

2022

Volltextzugriff (PDF)

Motoric engagement, but not decision-making, during encoding influences route memory

Spatial cognition and computation, 2024-05, p.1-26

2024

Volltextzugriff (PDF)

A weighted log‐rank test and associated effect estimator for cancer trials with delayed treatment effect

Pharmaceutical statistics : the journal of the pharmaceutical industry, 2021-05, Vol.20 (3), p.528-550

2021

Volltextzugriff (PDF)

T-cell receptor pharmacodynamics associated with survival and response to tremelimumab (T) in combination with durvalumab (D) in patients (pts) with unresectable hepatocellular carcinoma (uHCC)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.4087-4087

2021

Volltextzugriff (PDF)

Exposure-response (E-R) efficacy and safety (E-S) analyses of tremelimumab as monotherapy or in combination with durvalumab in patients (pts) with unresectable hepatocellular carcinoma (uHCC)

Journal of clinical oncology, 2021-01, Vol.39 (3_suppl), p.313-313

2021

Volltextzugriff (PDF)

A phase III, randomized, open label, multicenter, global study of first-line (1L) durvalumab in combination with standard of care (SOC) chemotherapy and durvalumab in combination with tremelimumab and SOC chemotherapy versus SOC chemotherapy alone in patients with unresectable locally advanced or metastatic urothelial cancer (UC)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.TPS4590-TPS4590

2019

Volltextzugriff (PDF)

Phase 3 randomized, open-label, multicenter study of tremelimumab (T) and durvalumab (D) as first-line therapy in patients (pts) with unresectable hepatocellular carcinoma (uHCC): HIMALAYA

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.379-379

2022

Volltextzugriff (PDF)

A Systematic Review of Adaptive Seamless Clinical Trials for Late-Phase Oncology Development

Therapeutic innovation & regulatory science, 2024-09, Vol.58 (5), p.917-929

2024

Volltextzugriff (PDF)

Use of Seamless Study Designs in Oncology Clinical Development– A Survey Conducted by IDSWG Oncology Sub-team

Therapeutic innovation & regulatory science, 2024-09, Vol.58 (5), p.978-986

2024

Volltextzugriff (PDF)

Plasma-based tumor mutational burden (bTMB) as predictor for survival in phase III EAGLE study: Durvalumab (D) ± tremelimumab (T) versus chemotherapy (CT) in recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) after platinum failure

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.6511-6511

2020

Volltextzugriff (PDF)

Efficacy, tolerability, and biologic activity of a novel regimen of tremelimumab (T) in combination with durvalumab (D) for patients (pts) with advanced hepatocellular carcinoma (aHCC)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.4508-4508

2020

Volltextzugriff (PDF)

Study of the Mechanisms of Cadmium Biosorption by Dealginated Seaweed Waste

Environmental science & technology, 2001-07, Vol.35 (14), p.3025-3030

2001

Volltextzugriff (PDF)

The Investigation of Unexpected Arsenic Compounds Observed in Routine Biological Monitoring Urinary Speciation Analysis

Toxics (Basel), 2017-05, Vol.5 (2), p.12

2017

Volltextzugriff (PDF)

Water-soluble gold nanoparticles stabilized with cationic phosphonium thiolate ligands

RSC advances, 2012-01, Vol.2 (27), p.10345-10351

2012

Volltextzugriff (PDF)

1 – 25 von 583.408

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(406.616)
Mit Volltextzugriff
(456.332)

Publikationsform

14 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(580.549)
Japanisch
(37.142)
Deutsch
(1.393)
Französisch
(906)
Portugiesisch
(443)
Spanisch
(194)
Russisch
(190)
Norwegisch
(177)
Afrikaans
(119)
Koreanisch
(113)
Niederländisch
(90)
Chinesisch
(79)
Italienisch
(59)
Katalanisch
(56)
Dänisch
(38)
Bulgarisch
(24)
Polnisch
(24)
Croatian
(20)
Arabisch
(16)
Schwedisch
(16)

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(229.147)
Life Sciences & Biomedicine
(161.211)
Humans
(108.696)
Female
(54.705)
Male
(54.223)
Biological And Medical Sciences
(45.105)
Physical Sciences
(43.895)
Animals
(37.211)
Technology
(35.751)
Social Sciences
(34.458)
Adult
(31.951)
Medical Sciences
(30.915)
Middle Aged
(29.138)
Aged
(21.992)
Chemistry
(19.944)
Engineering
(16.496)
Fundamental And Applied Biological Sciences. Psychology
(16.158)
Science & Technology - Other Topics
(14.619)
Biochemistry & Molecular Biology
(14.604)
Physics
(13.756)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

IngentaConnect
(173.023)
EZB Electronic Journals Library
(172.876)
MEDLINE
(144.852)
Journals@Ovid Complete
(120.677)
Publisher or Other Site
(116.135)
JSTOR
(80.534)
Elsevier ScienceDirect Journals Complete
(75.711)
IngentaConnect Journals
(73.551)
Wiley Online Library
(64.066)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(51.630)
Ebook Central Perpetual and DDA
(45.767)
eBooks on EBSCOhost
(42.104)
Wiley Online Library Full Collection 2018
(41.292)
Business Source Ultimate
(33.071)
Nexis Uni
(27.847)
Springer Journals
(25.555)
Taylor & Francis
(24.105)
Oxford Journals
(23.520)
Taylor & Francis:Master (3349 titles)
(23.448)
Access via Taylor & Francis
(23.080)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Nature
(3.494)
Scientific American
(3.431)
Plos One
(3.405)
Science
(3.002)
Blood
(2.679)
The Journal Of Biological Chemistry
(2.272)
Proceedings Of The National Academy Of Sciences - Pnas
(2.152)
Journal Of Clinical Oncology
(2.069)
Bmj
(2.063)
Journal Of The American Chemical Society
(2.062)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3.671)
... seit 30 Tagen
(1.257)

Menü

Weitere Dienste

Einstellungen

Towards Effective Implementation of Carbon Reduction Strategies in Construction Procurement: A Case Study of New Zealand

Augmenting external control arms using Bayesian borrowing: a case study in first-line non-small cell lung cancer

Microbial Transformations of Selenium Species of Relevance to Bioremediation

266 Tumour mutation burden (TMB) and efficacy outcomes in the phase III DANUBE study of advanced urothelial carcinoma (UC)

Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study

Methyl Selenol as a Precursor in Selenite Reduction to Se/S Species by Methane-Oxidizing Bacteria

Factors Influencing the Surface Functionalization of Citrate Stabilized Gold Nanoparticles with Cysteamine, 3-Mercaptopropionic Acid or l-Selenocystine for Sensor Applications

Development of a method for the simultaneous detection of Cr(iii) and Cr(vi) in exhaled breath condensate samples using μLC-ICP-MS

Exposure-Response Analyses of Tremelimumab Monotherapy or in Combination with Durvalumab in Patients with Unresectable Hepatocellular Carcinoma

A phase 3 randomized, double-blind, placebo-controlled, multicenter, global study of durvalumab with and after chemoradiotherapy in patients with locally advanced, unresectable esophageal squamous cell carcinoma: KUNLUN

Tumor Mutational Burden as a Predictor of Survival with Durvalumab and/or Tremelimumab Treatment in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Research productivity and impact of Canadian academic ophthalmologists: trends in H-index, gender, subspecialty, and faculty appointment

Motoric engagement, but not decision-making, during encoding influences route memory

A weighted log‐rank test and associated effect estimator for cancer trials with delayed treatment effect

T-cell receptor pharmacodynamics associated with survival and response to tremelimumab (T) in combination with durvalumab (D) in patients (pts) with unresectable hepatocellular carcinoma (uHCC)

Exposure-response (E-R) efficacy and safety (E-S) analyses of tremelimumab as monotherapy or in combination with durvalumab in patients (pts) with unresectable hepatocellular carcinoma (uHCC)

Phase 3 randomized, open-label, multicenter study of tremelimumab (T) and durvalumab (D) as first-line therapy in patients (pts) with unresectable hepatocellular carcinoma (uHCC): HIMALAYA

A Systematic Review of Adaptive Seamless Clinical Trials for Late-Phase Oncology Development

Use of Seamless Study Designs in Oncology Clinical Development– A Survey Conducted by IDSWG Oncology Sub-team

Plasma-based tumor mutational burden (bTMB) as predictor for survival in phase III EAGLE study: Durvalumab (D) ± tremelimumab (T) versus chemotherapy (CT) in recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) after platinum failure

Efficacy, tolerability, and biologic activity of a novel regimen of tremelimumab (T) in combination with durvalumab (D) for patients (pts) with advanced hepatocellular carcinoma (aHCC)

Study of the Mechanisms of Cadmium Biosorption by Dealginated Seaweed Waste

The Investigation of Unexpected Arsenic Compounds Observed in Routine Biological Monitoring Urinary Speciation Analysis

Water-soluble gold nanoparticles stabilized with cationic phosphonium thiolate ligands

Suchergebnisse filtern